Prevalence and trend of hypertension among the elderly persons in Kiruddu Referral Hospital, Kampala District

D. Mercey Kemigisa¹ , A. Mugeere² , S. Mirembe³

Section:Research Paper, Product Type: Journal-Paper
Vol.9 , Issue.5 , pp.5-13, May-2023

Online published on May 31, 2023

Copyright © D. Mercey Kemigisa, A. Mugeere, S. Mirembe . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

Abstract :
The study mainly examines the prevalence and trend of hypertension among elderly persons in Kampala. The study adopts a cross – sectional research design. The study collected both quantitative and qualitative information. Data was collected from 151 respondents at Kiruddu Referral Hospital and six key informants at a single point in time. Quantitative data analysis was done using SPSS while qualitative analysis was done using Jamovi and thematic approach. Findings show that majority (87%) of respondents reported that the rate of hypertension is high among the elderly persons. The study also observed that hypertension is a leading killer disease among elderly persons and is further responsible for disabilities, stroke, heart disease, and kidney failure. Therefore the study concludes by suggesting that there is need for a life course approach to hypertension prevention and also there is need to create awareness about hypertension amidst other several hypertension reduction approaches.

Key-Words / Index Term :
Prevalence, Hypertension, Hospital, elderly, mortality, morbidity

References :
[1] N. Keyfitz and W. Flieger, “World population growth and aging,” Univ. Chic. Press Econ. Books, 1991.
[2] M. Roser and H. Ritchie, “Homicides,” Our World Data, 2013.
[3] Y. Xie et al., “Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016,” Kidney Int., vol. 94, no.3, pp.567–581, 2018.
[4] World Population Review, “Population of Cities in Uganda (2019),” Kampala - Uganda, 2018.
[5] V. Peberdy, “Hypertension: putting the pressure on the silent killer,” Int Fed Pharm Manuf Assoc, vol.2, pp.1–19, 2016.
[6] World Health Organization, Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization, 2009.
[7] P. Lloyd-Sherlock, S. Ebrahim, and H. Grosskurth, “Is hypertension the new HIV epidemic?,” Int. J. Epidemiol., vol. 43, no.1, pp.8–10, 2014.
[8] WHO, “The health of the people: what works.,” 2013.
[9] World Health Organization, “Global Burden of Disease. Projections of mortality and burden of disease, 2002–2030.,” 2014.
[10] S. Dalal et al., “Non-communicable diseases in sub-Saharan Africa: what we know now,” Int. J. Epidemiol., vol.40, no.4, pp.885–901, 2011.
[11] L. H. Opie and Y. K. Seedat, “Hypertension in sub-Saharan African populations,” Circulation, vol.112, no.23, pp.3562–3568, 2005.
[12] C. J. Murray and A. D. Lopez, “Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study,” The lancet, vol. 349, no.9063, pp.1436–1442, 1997.
[13] K. Hofman, A. Ryce, W. Prudhomme, and S. Kotzin, “Reporting of non-communicable disease research in low-and middle-income countries: a pilot bibliometric analysis,” J. Med. Libr. Assoc. JMLA, vol. 94, no.4, p.415, 2006.
[14] M. D. Holmes et al., “Non-communicable diseases in sub-Saharan Africa: the case for cohort studies,” PLoS Med., vol.7, no.5, pp.e1000244, 2010.
[15] J. Mufunda et al., “The prevalence of hypertension and its relationship with obesity: results from a national blood pressure survey in Eritrea,” J. Hum. Hypertens., vol.20, no.1, pp.59–65, 2006.
[16] R. A. Adedoyin et al., “Prevalence and pattern of hypertension in a semiurban community in Nigeria,” Eur. J. Prev. Cardiol., vol.15, no.6, pp.683–687, 2008.
[17] Z. M. Ofuya, “The incidence of hypertension among a select population of adults in the Niger Delta region of Nigeria,” Southeast Asian J. Trop. Med. Public Health, vol.38, no.5, pp.947, 2007.
[18] D. Lasky, E. Becerra, W. Boto, M. Otim, and J. Ntambi, “Obesity and gender differences in the risk of type 2 diabetes mellitus in Uganda,” Nutrition, vol.18, no.5, pp.417–421, 2002.
[19] D. Maher, L. Waswa, K. Baisley, A. Karabarinde, N. Unwin, and H. Grosskurth, “Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda,” Int. J. Epidemiol., vol.40, no.1, pp.160–171, 2011.
[20] A. P. Kengne, A. G. Amoah, and J.-C. Mbanya, “Cardiovascular complications of diabetes mellitus in sub-Saharan Africa,” Circulation, vol.112, no.23, pp.3592–3601, 2005.
[21] H. Greenberg, S. U. Raymond, and S. R. Leeder, “Cardiovascular Disease And Global Health: Threat And Opportunity: Cardiovascular disease is a new problem for the less developed world to contemplate.,” Health Aff. (Millwood), vol. 24, no. Suppl1, pp. W5-31, 2005.
[22] K. Strong, C. Mathers, S. Leeder, and R. Beaglehole, “Preventing chronic diseases: how many lives can we save?,” The Lancet, vol.366, no.9496, pp.1578–1582, 2005.
[23] J. Whitworth, “Emerging drugs in the management of hypertension,” Expert Opin. Emerg. Drugs, vol.8, no.2, pp.377–388, 2003.
[24] S. Lewington, “Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies,” Lancet, vol.360, no.9349, pp.1903–1913, 2002.
[25] G. Musinguzi and F. Nuwaha, “Prevalence, awareness and control of hypertension in Uganda,” PloS One, vol.8, no.4, pp.e62236, 2013.
[26] M. Pereira, N. Lunet, A. Azevedo, and H. Barros, “Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries,” J. Hypertens., vol.27, no. 5, pp.963–975, 2009.
[27] Ministry of Health, “Health sector strategic and investment plan.,” Ministry of Health, Kampala - Uganda., 2010.
[28] A. Dzudie et al., “Kingue S; CCS investigator group: Prevalence, awareness, treatment and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional study,” BMJ Open, vol.2, no.4, pp.e001217, 2012.
[29] M. Twagirumukiza, D. De Bacquer, J. G. Kips, G. de Backer, R. Vander Stichele, and L. M. Van Bortel, “Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies,” J. Hypertens., vol.29, no.7, pp.1243–1252, 2011.
[30] O. Namusisi et al., “Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,” Pan Afr. Med. J., vol.10, 2011.
[31] J. I. Schwartz, D. Guwatudde, R. Nugent, and C. M. Kiiza, “Looking at non-communicable diseases in Uganda through a local lens: an analysis using locally derived data,” Glob. Health, vol.10, pp.1–9, 2014.
[32] A. A. Hyder, “Application of Burden of Disease Analyses in Developing Countries: Implication for policy, planning and management of health systems,” Global Forum for Health Research, 2006.
[33] A. A. Barros, M. V. C. Guedes, D. de J. M. Moura, L. C. G. de Menezes, L. L. Aguiar, and G. A. Xavier, “Health behaviors of people with hypertension: health belief model,” Northeast Netw. Nurs. J., vol.15, no.3, 2014.
[34] A. S. Singh and M. B. Masuku, “Sampling techniques & determination of sample size in applied statistics research: An overview,” Int. J. Econ. Commer. Manag., vol.2, no.11, pp.1–22, 2014.
[35] M. M. Ibrahim, “Hypertension surveys in the developing world. Lessons from the Egyptian National Hypertension Project (NHP),” J. Hum. Hypertens., vol.11, no.11, pp.709–726, 1997.
[36] R. Gupta, “Trends in hypertension epidemiology in India,” J. Hum. Hypertens., vol.18, no.2, pp.73–78, 2004.
[37] D. Guwatudde et al., “The epidemiology of hypertension in Uganda: findings from the national non-communicable diseases risk factor survey,” PloS One, vol.10, no.9, pp.e0138991, 2015.
[38] J. K. Soubeiga, T. Millogo, B. W. Bicaba, B. Doulougou, and S. Kouanda, “Prevalence and factors associated with hypertension in Burkina Faso: a countrywide cross-sectional study,” BMC Public Health, vol.17, pp.1–8, 2017.
[39] Government of Uganda, “CONSTITUTION OF THE REPUBLIC OF UGANDA.,” 1995.
[40] United Nations, “World population prospects: Key findings and advance tables.,” UN, 2017.
[41] I. Aboderin and M. Ferreira, “Linking ageing to development agendas in sub-Saharan Africa: Challenges and approaches,” J. Popul. Ageing, vol.1, pp. 51–73, 2008.
[42] I. UBOS, “Uganda Bureau of statistics (UBOS) and ICF. 2018,” Uganda Demogr. Health Surv., 2016.
[43] P. Kowal et al., “Ageing and adult health status in eight lower-income countries: the INDEPTH WHO-SAGE collaboration,” Glob. Health Action, vol.3, no.1, p.5302, 2010.
[44] K. Hjelm and F. Atwine, “Health-care seeking behaviour among persons with diabetes in Uganda: an interview study,” BMC Int. Health Hum. Rights, vol.11, no.1, pp.1–8, 2011.
[45] Uganda Bureau of Statistics, “The National Population and Housing Census 2014 – Area Specific Profile Serie,” Kampala Uganda., 2017.
[46] I. Hajjar and T. A. Kotchen, “Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000,” Jama, vol.290, no.2, pp.199–206, 2003.